HEALTHFRANCE 24
Mass rollout planned across Southern Africa for new HIV drug
The HIV drug Lenacapavir, offering over 99% protection and administered twice yearly, is set for mass rollout in Southern Africa. The treatment has been approved after years of research and will be distributed across South Africa, Zambia, Eswatini, Zimbabwe, Lesotho, and Mozambique.
Mentioned
Related Signal
Adjacent reporting
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
- Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
- South Africa rolls out new preventive HIV shot in 'major turning point'
- Exclusive: Race begins to trial Ebola drugs amid current outbreak